Oncozenge AB (ONCOZ) — Cash Flow-to-Debt Ratio
Oncozenge AB (ONCOZ) has a Cash Flow-to-Debt Ratio of -0.45x as of December 2025, meaning its operating cash flow of Skr-7.24 Million could theoretically repay 0% of its total liabilities (Skr15.92 Million) in one year. See ONCOZ cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncozenge AB Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Oncozenge AB across 6 annual periods. Also explore Oncozenge AB (ONCOZ) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Oncozenge AB (2020–2025)
Year-by-year debt coverage analysis for Oncozenge AB. For market capitalisation and broader financial context, see Oncozenge AB market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.82x | Skr-13.06 Million | Skr15.92 Million | ▲ +86.1% |
| 2024 | -5.91x | Skr-8.76 Million | Skr1.48 Million | ▲ +41.3% |
| 2023 | -10.05x | Skr-17.08 Million | Skr1.70 Million | ▼ -33.0% |
| 2022 | -7.56x | Skr-22.08 Million | Skr2.92 Million | ▼ -677.8% |
| 2021 | -0.97x | Skr-4.77 Million | Skr4.90 Million | ▼ -876118.1% |
| 2020 | 0.00x | Skr-1.00K | Skr9.01 Million | — |